Background
Chagas disease, EH
DISEASE, CHAGAS DISEASE
I have read the journal’s policy and the authors of this manuscript have the following competing interests: AMR and JA are members of the Research Career of CONICET, Argentina. JA has acted as a consultant to Bayer for the design, conduct and review of the CHICO and CHICO SECURE studies. UG is an employee of Bayer AG. EH is an employee of Bayer US LLC.¶ Membership of the CHICO and CHICO SECURE study groups is provided in Measurement of the success of antitrypanosomal treatment for Chagas disease is difficult, particularly in the chronic phase of the disease, because anti-